Treatment of hemoglobin Bart's hydrops with bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Jornal de Pediatria

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-3476(98)70406-8PMID 9627601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In utero haematopoietic stem cell transplantation: current perspectives and future potential.

  1996cited by this paper
• Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia.

  1996cited by this paper
• Intrauterine therapy for homozygous alpha-thalassemia.

  1995cited by this paper
• Bone marrow transplantation in thalassemia.

  1995cited by this paper
• A Perinatal Audit of Stillbirths in a Teaching Hospital in Hong Kong

  1994cited by this paper
• Long-term survival of a baby with homozygous alpha-thalassemia-1.

  1992cited by this paper
• Rapid diagnosis of alpha-thalassemia-1 of southeast Asia type and hydrops fetalis by polymerase chain reaction.

  1991cited by this paper
• Rapid diagnosis of alpha-thalassemia-1 of southeast Asia type and hydrops fetalis by polymerase chain reaction [letter]

  1991cited by this paper
• Survival of a hydropic infant with homozygous α-thalassemia-1

  1986cited by this paper
• Normal long-term survival with alpha-thalassemia.

  1986cited by this paper
• Survival of a hydropic infant with homozygous alpha-thalassemia-1.

  1986cited by this paper
• Normal long-term survival with α-thalassemia

  1986cited by this paper

• Haemoglobin Bart's Hydrops Fetalis: Charting the Past and Envisioning the Future.

  2024cites this paper
• Αlpha-thalassemia: A practical overview.

  2024cites this paper
• Placenta-Derived Extracellular Vesicles in Pregnancy Complications and Prospects on a Liquid Biopsy for Hemoglobin Bart’s Disease

  2023cites this paper
• Advances in the management of α-thalassemia major: reasons to be optimistic.

  2021cites this paper
• Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia

  2021cites this paper
• Outcomes of allogeneic transplantation for hemoglobin Bart’s hydrops fetalis syndrome in Hong Kong

  2021cites this paper
• Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis

  2020influential citation
• Fetal hemoglobin Bart’s hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment

  2018cites this paper
• Homozygous α‐thalassemia: Challenges surrounding early identification, treatment, and cure

  2017cites this paper
• New trend in the epidemiology of thalassaemia.

  2017cites this paper
• Association of Tissue-Specific DNA Methylation Alterations with α-Thalassemia Southeast Asian Deletion

  2017cites this paper
• An international registry of survivors with Hb Bart's hydrops fetalis syndrome.

  2017cites this paper
• Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease

  2016cites this paper
• Treatment of alpha(0)-thalassemia (--SEA/--SEA) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?

  2015cites this paper
• Normal cognitive functioning in a patient with Hb Bart’s hydrops successfully cured by hematopoietic SCT

  2014cites this paper
• Successful Unrelated Cord Blood Transplantation For Homozygous &agr;-Thalassemia

  2013cites this paper
• Chapter 77 – Erythrocyte Disorders in Infancy

  2012cites this paper
• Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation.

  2009cites this paper
• The changing face of haemolytic disease of the newborn.

  2008cites this paper
• Haemolytic disease of the newborn

  2007cites this paper
• Fetal gene therapy of alpha-thalassemia in a mouse model.

  2007cites this paper
• Outcome of intensive care of homozygous alpha‐thalassaemia without prior intra‐uterine therapy

  2007cites this paper
• Fetal gene therapy of α-thalassemia in a mouse model

  2007cites this paper
• Neonatal Hematology: Frontmatter

  2005cites this paper
• Neonatal Hematology: Neonatal hemolysis

  2005cites this paper
• Fetal therapy for single gene disorders.

  2005cites this paper
• Chronic zinc toxicity in an infant who received zinc therapy for atopic dermatitis

  2005cites this paper
• Neurodevelopmental outcome and haematological course of a long‐time survivor with homozygous alpha‐thalassaemia: Case report and review of the literature

  2005cites this paper
• Vascular‐type disruptive defects in fetuses with homozygous α‐thalassemia: report of two cases and review of the literature

  2005cites this paper
• Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review.

  2004cites this paper
• Hydrops Fetalis Caused by Homozygous α-Thalassemia and Rh Antigen Alloimmunization: Report of a Survivor and Literature Review

  2004cites this paper
• Homozygous α-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation

  2003cites this paper
• Testing for hematologic disorders and complications.

  2003cites this paper
• Pulmonary hypoplasia and persistent pulmonary hypertension in the newborn with homozygous α-thalassemia: a case report and review of the literature

  2003cites this paper
• Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation.

  2003cites this paper
• Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study.

  2002cites this paper
• Successful mismatched sibling cord blood transplant in Hb Bart's disease

  2001cites this paper
• Changing outcome of homozygous alpha-thalassemia: cautious optimism.

  2000cites this paper
• Bone marrow transplantation for hemoglobinopathies.

  2000cites this paper
• Alpha-thalassemia syndromes: from clinical and molecular diagnosis to bedside management

  year unknowncites this paper